Tadamitsu Kishimoto
Active 1973–2025
- Also published as
- Tadamitsu Kishimoto†
- 286
- Papers
- 96,885
- Citations
- 168
- h-index
- 284
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine51.2%
- Biochemistry, Genetics and Molecular Biology19.9%
- Immunology and Microbiology19.1%
- Neuroscience5.8%
- Agricultural and Biological Sciences0.7%
- Environmental Science0.6%
- Other2.7%
Topics
- Cytokine Signaling Pathways and Interactions5.4%
- Immune Cell Function and Interaction4.1%
- T-cell and B-cell Immunology3.3%
- Immune Response and Inflammation3%
- Immunotherapy and Immune Responses2.3%
- Chemokine receptors and signaling1.7%
- Other80.2%
Coauthors
- Tetsuya Taga45
- Kazuyuki Yoshizaki35
- Shizuo Akira32
- Tetsuji Naka27
- Masashi Narazaki26
- Toshio Hirano24
- Toshio Tanaka22
- Norihiro Nishimoto21
- Minoru Fujimoto17
- Akihiro Kimura15
- Hitoshi Kikutani15
- Keiko Yamauchi‐Takihara15
- Kiyoshi Yasukawa15
- T Hirano14
- Yasushi Fujio12
- Sujin Kang11
- Yoshiyuki Ohsugi10
- Atsushi Ogata9
- Hamza Hanieh9
- Hozaifa Metwally9
- Kazuya Masuda9
- Keita Kunisada9
- Kishan Kumar Nyati9
- Kiyoshi Takeda9
All papers
- IL‐6: Regulator of Treg/Th17 balance
Authors: Akihiro Kimura, Tadamitsu Kishimoto - European Journal of Immunology 2010 cited by 1,572
- Translating IL-6 biology into effective treatments
Authors: Ernest Choy, Fabrizio De Benedetti, Tsutomu Takeuchi, Misato Hashizume, Markus R. John, Tadamitsu Kishimoto - Nature Reviews Rheumatology 2020 cited by 697
- Targeting Interleukin-6 Signaling in Clinic
Authors: Sujin Kang, Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto - Immunity 2019 cited by 894
- Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
Authors: Sujin Kang, Tadamitsu Kishimoto - Experimental & Molecular Medicine 2021 cited by 370
- Historical overview of the interleukin-6 family cytokine
Authors: Sujin Kang, Masashi Narazaki, Hozaifa Metwally, Tadamitsu Kishimoto - The Journal of Experimental Medicine 2020 cited by 356
- Interleukin (IL-6) Immunotherapy
Authors: Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto - Cold Spring Harbor Perspectives in Biology 2017 cited by 413
- Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism
Authors: Nam‐Trung Nguyen, Akihiro Kimura, Taisuke Nakahama, Ichino Chinen, Kazuya Masuda, Keiko Nohara, Yoshiaki Fujii‐Kuriyama, Tadamitsu Kishimoto - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 668
- IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
Authors: Sujin Kang, Toshio Tanaka, Hitomi Inoue, Chikako Ono, Shoji Hashimoto, Yoshiyuki Kioi, Hisatake Matsumoto, Hiroshi Matsuura, Tsunehiro Matsubara, Kentaro Shimizu, Hiroshi Ogura, Yoshiharu Matsuura, Tadamitsu Kishimoto - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 334
- IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Authors: Tadamitsu Kishimoto, Sujin Kang - Annual Review of Immunology 2022 cited by 128
- Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
Authors: Raja Atreya, Jonas Mudter, Susetta Finotto, Jürgen Müllberg, Thomas Jostock, Stefan Wirtz, M.M. Schutz, Brigitte Bartsch, Martin Holtmann, Christoph Becker, David Strand, J. Czaja, JF Schlaak, Hans A. Lehr, Frank Autschbach, G. Schürmann, Naoki Nishimoto, Kazuyuki Yoshizaki, Hiroaki Ito, Tadamitsu Kishimoto, Peter R. Galle, Stefan Rose‐John, Markus F. Neurath - Nature Medicine 2000 cited by 1,289
- Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Authors: Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto - Immunotherapy 2016 cited by 737
- Essential role of Stat6 in IL-4 signalling
Authors: Kiyoshi Takeda, Takashi Tanaka, Wei Shi, Makoto Matsumoto, Masashi Minami, Shin‐ichiro Kashiwamura, Kenji Nakanishi, Nobuaki Yoshida, Tadamitsu Kishimoto, Shizuo Akira - Nature 1996 cited by 1,577
- Impaired immune and acute-phase responses in interleukin-6-deficient mice
Authors: Manfred Köpf, Heinz Baumann, Giulia Freer, Marina A. Freudenberg, Marinus C. Lamers, Tadamitsu Kishimoto, Rolf M. Zinkernagel, Horst Bluethmann, Georges Köhler - Nature 1994 cited by 1,798
- INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Authors: Tadamitsu Kishimoto - Annual Review of Immunology 2004 cited by 1,018
- Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Authors: Kiyoshi Takeda, Koichi Noguchi, Wei Shi, Takashi Tanaka, Makoto Matsumoto, Nobuaki Yoshida, Tadamitsu Kishimoto, Shizuo Akira - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 1,335
- TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Authors: Christoph Becker, Massimo Claudio Fantini, Christoph Schramm, Hans A. Lehr, Stefan Wirtz, Alexei Nikolaev, Jürgen Burg, Susanne Strand, Ralf Kießlich, Samuel Huber, Hiroaki Ito, Norihiro Nishimoto, Kazuyuki Yoshizaki, Tadamitsu Kishimoto, Peter R. Galle, Manfred Blessing, Stefan Rose‐John, Markus F. Neurath - Immunity 2004 cited by 719
- Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
Authors: Takahiro Hashimoto-Kataoka, Naoki Hosen, Takashi Sonobe, Yoh Arita, Taku Yasui, Takeshi Masaki, Masato Minami, Tadakatsu Inagaki, Shigeru Miyagawa, Yoshiki Sawa, Masaaki Murakami, Atsushi Kumanogoh, Keiko Yamauchi‐Takihara, Meinoshin Okumura, Tadamitsu Kishimoto, Issei Komuro, Mikiyasu Shirai, Yasushi Sakata, Yoshikazu Nakaoka - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 257
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
Authors: Toshio Hirano, Kiyoshi Yasukawa, Hisashi Harada, Tetsuya Taga, Yasuo Watanabe, Tadashi Matsuda, Shin‐ichiro Kashiwamura, Koichi Nakajima, Koichi Koyama, Akihiro Iwamatsu, Susumu Tsunasawa, Fumio Sakiyama, Hiroshi Matsui, Yoshiyuki Takahara, Tadatsugu Taniguchi, Tadamitsu Kishimoto - Nature 1986 cited by 2,166
- TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a
Authors: Kishan Kumar Nyati, Kazuya Masuda, Mohammad Mahabub-Uz Zaman, Praveen Kumar Dubey, David Millrine, Jaya Prakash Chalise, Mitsuru Higa, Songling Li, Daron M. Standley, Kazunobu Saito, Hamza Hanieh, Tadamitsu Kishimoto - Nucleic Acids Research 2017 cited by 221
- Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses
Authors: Akihiro Kimura, Tetsuji Naka, Taisuke Nakahama, Ichino Chinen, Kazuya Masuda, Keiko Nohara, Yoshiaki Fujii‐Kuriyama, Tadamitsu Kishimoto - The Journal of Experimental Medicine 2009 cited by 405
- Regulation of IL-6 in Immunity and Diseases
Authors: Toshio Tanaka, Masashi Narazaki, Kazuya Masuda, Tadamitsu Kishimoto - Advances in experimental medicine and biology 2016 cited by 225
- Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Authors: Norihiro Nishimoto, Yuzuru Kanakura, Katsuyuki Aozasa, Takeshi Johkoh, Minoru Nakamura, Shuji Nakano, Nobuaki Nakano, Yasuo Ikeda, Takeshi Sasaki, Kiyoshi Nishioka, Masamichi Hara, Hirokuni Taguchi, Yukihiko Kimura, Yoshiro Kato, Hideki Asaoku, Shunichi Kumagai, Fumio Kodama, Hideko Nakahara, Keisuke Hagihara, Kazuyuki Yoshizaki, Tadamitsu Kishimoto - Blood 2005 cited by 750
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Authors: Tetsuya Taga, Masahiko Hibi, Yuuichi Hirata, Katsuhiko Yamasaki, Kiyoshi Yasukawa, T Matsuda, Toshio Hirano, Tadamitsu Kishimoto - Cell 1989 cited by 1,412
- The role and therapeutic targeting of IL-6 in rheumatoid arthritis
Authors: Masashi Narazaki, Toshio Tanaka, Tadamitsu Kishimoto - Expert Review of Clinical Immunology 2017 cited by 230
